Publications

2016
18 April

Civil Society Urges Member States to Support the Dutch EU Presidency’s Vision on Access to Affordable Medicines
14 April

Trade Secrets Directive Will Threaten Access to Medicines Safety and Efficacy Data
14 April

Insulin Trade Profile
7 April

ACCISS Study Reveals Numerous Barriers Hindering Access to Insulin for Millions in Need
5 April

HAI Intervention on Ensuring Access to Antimicrobial Drugs, Diagnostics and Vaccines
15 March

Assessing EU Funding for R&D for Poverty-related and Neglected Diseases
10 March

HAI Intervention at the United Nations High-Level Panel on Access to Medicines
22 February

Access to High-priced Medicines in Hospital Settings in Europe: A Study in Four European Countries
22 February

Study Finds Access to High-priced Medicines May Differ Across EU
18 February

Why You Should Be Concerned About TTIP and Access to Medicines
6 February

Listen: ACCISS Study Investigator, David Beran, Speaks to The Lancet D&E About Insulin Access
27 January

European CSOs Call for Rejection of EU Trade Secrets Directive
25 January

Civil Society Has No Confidence in Stalled Framework for Engagement with Non-state Actors Process
2015
23 December

PRIME Example of How EMA is Pushing for Accelerated Market Approvals
3 December

Trilogue Negotiations on Commission’s Proposal for Trade Secrets Directive
1 December

Medicines Transparency Alliance (MeTA) Evaluation
19 November

Global Snakebite Initiative Appoints Health Action International as Secretariat
27 October

Multi-sectoral NGO Coalition Calls on Parliament to Defend Safeguards for Consumers, Journalists, Whistleblowers, Public Authorities and Workers
16 October

“Adaptive Licensing” or “Adaptive Pathways”: Deregulation Under the Guise of Earlier Access
16 October

NVTG Congres richt zich op toegang tot geneesmiddelen
14 October

Empty Gestures – The EU’s Commitments to Safeguard Access to Medicines
14 October

HAI and MSF Report Shows European Commission’s Access to Medicines Commitments are ‘Empty Gestures’
30 September

EU medicines policy & access to medicines
30 September

Early Access to Medicines Marketing Authorisation Flexibilities Should Only Respond to Unmet Medical Needs, Must Protect Patient Safety
16 September

Direct Patient Reporting in the EU: A Snapshot of Reporting Systems in Seven Member States
18 August

Declaration of Public Interest Regarding Access to Imatinib (Glivec) in Colombia
8 July

Health Action International Opposes European Parliament’s ISDS Compromise in TTIP
7 July

EU Medicines Policy and Access to Medicines
2 July

Health Groups Call on European Medicines Agencies to Address Independence and Transparency Problems
29 June

HAI Sexual Harassment Policy